Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements
August 31, 2023 06:24 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements
August 31, 2023 06:22 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements
August 31, 2023 06:19 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
AstraZeneca, Pfizer Inc., and Novartis AG Spearhead Innovation in Tuberculosis Therapeutics Amid Rising Global Prevalence
July 20, 2023 05:18 ET
|
Research and Markets
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "Tuberculosis Therapeutics Market Size, Share & Trends Analysis Report By Disease Type (Active TB, Latent TB), By Therapy, By Route Of...
Global Idiopathic Pulmonary Fibrosis (IPF) Market to 2029: Players Include Boehringer Ingelheim, F. Hoffmann-La Roche, Cipla and Shionogi & Co
July 13, 2023 04:33 ET
|
Research and Markets
Dublin, July 13, 2023 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis (IPF) Market (2023 Edition): Analysis By Drug Type (Pirfenidone, Nintedanib, Others), Route of Administration...
Global Asthma & COPD Therapies Market Report 2023-2033: Expansion into Emerging Markets to Offer Lucrative Growth Opportunities
June 28, 2023 04:38 ET
|
Research and Markets
Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The "Asthma & COPD Therapies Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Asthma & COPD Therapies Market...
Global Idiopathic Pulmonary Fibrosis Market Report 2023: Sector is Expected to Reach $7.52 Billion by 2030 at a CAGR of 8.7%
June 15, 2023 08:03 ET
|
Research and Markets
Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Market, By Drug, By Route of Administration, By Distribution Channel, and By Geography - Size, Share, Outlook, and...
Bronchodilators Global Market Report 2023: Sector to Reach $45 Billion by 2030 at a 4.7% CAGR
June 15, 2023 04:38 ET
|
Research and Markets
Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Bronchodilators - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Bronchodilators Market to Reach...
Global Bronchodilators Market to 2030: Increasing Prevalence of Lung Diseases Drives Growth
June 06, 2023 06:28 ET
|
Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Bronchodilators Market Size, Share & Trends Analysis Report By Disease (Asthma, COPD), By Route Of Administration (Inhalable, Oral), By Drug Class...
Global Respiratory Disease Partnering Analysis Report 2023: Deal Trends, Players and Financials for Deals Signed Since 2010
June 01, 2023 08:53 ET
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Global Respiratory Partnering 2010-2023: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.Global...